Clinical Trials Browser

Phase 3 × Terminated × Amifampridine × Clear all

NCT03579966 2024-05-07

Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Phase 3 Terminated

63 enrolled 10 charts

Myasthenia Gravis